Immatics N.V. (IMTX) P/E Ratio History
Historical price-to-earnings valuation from 2022 to 2024
Loading P/E history...
IMTX Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Immatics N.V. (IMTX) trades at a price-to-earnings ratio of 67.8x, with a stock price of $11.14 and trailing twelve-month earnings per share of $-0.95.
The current P/E is 164% above its 5-year average of 25.7x. Over the past five years, IMTX's P/E has ranged from a low of 14.0x to a high of 47.8x, placing the current valuation at the 100th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, IMTX trades at a 204% premium to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, IMTX commands a significant premium over the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our IMTX DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
IMTX P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $7B | 15.5Lowest | -Best | +1747%Best |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
IMTX Historical P/E Data (2022–2024)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2024 Q4 | $7.11 | $0.15 | 47.8x | +86% | |
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $8.71 | $0.62 | 14.0x | -45% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $10.00 | $0.55 | 18.2x | -29% |
| FY2022 Q2 | $8.71 | $0.44 | 19.8x | -23% | |
| FY2022 Q1 | $7.99 | $0.28 | 28.5x | +11% |
Average P/E for displayed period: 25.7x
See IMTX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IMTX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IMTX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonIMTX — Frequently Asked Questions
Quick answers to the most common questions about buying IMTX stock.
Is IMTX stock overvalued or undervalued?
IMTX trades at 67.8x P/E, above its 5-year average of 25.7x. The 100th percentile ranking indicates a premium to historical valuation.
How does IMTX's valuation compare to peers?
Immatics N.V. P/E of 67.8x compares to sector median of 22.3x. The premium reflects expected growth above peers.
What is IMTX's PEG ratio?
IMTX PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2022-2024.